Clinical trial
Systemic Immunological Response of Bladder Cancer Patients Under Bacillus Calmette Guérin Treatment
NCT04806178 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systemic Immunological Response of Bladder Cancer Patients Under Bacillus Calmette Guérin Treatment
- Lead sponsor
- University of Campinas, Brazil
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 3, 2021
- Completion date
- August 18, 2024
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bacillus calmette-guerin, bladder cancer